Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ESTA Stock Forecast 2026-2027
$64.06
Current Price
$1.88B
Market Cap
Buy 8
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to ESTA Price Targets
+56.1%
To High Target of $100.00
+40.5%
To Median Target of $90.00
+1.5%
To Low Target of $65.00
ESTA Price Momentum
-3.8%
1 Week Change
+2.3%
1 Month Change
+122.6%
1 Year Change
-12.1%
Year-to-Date Change
-23.1%
From 52W High of $83.31
+123.4%
From 52W Low of $28.67
📊 TOP ANALYST CALLS
Did ESTA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Establishment Labs is one of their latest high-conviction picks.
Latest ESTA Stock Price Targets & Analyst Predictions
Based on our analysis of 14 Wall Street analysts, ESTA has a bullish consensus with a median price target of $90.00 (ranging from $65.00 to $100.00). The overall analyst rating is Strong Buy (9.1/10). Currently trading at $64.06, the median forecast implies a 40.5% upside. This outlook is supported by 8 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Anthony Petrone at Mizuho, projecting a 56.1% upside. Conversely, the most conservative target is provided by Marie Thibault at BTIG, suggesting a 1.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ESTA Analyst Ratings
8
Buy
1
Hold
0
Sell
ESTA Price Target Range
Low
$65.00
Average
$90.00
High
$100.00
Current: $64.06
Latest ESTA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ESTA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 11, 2026 | Citigroup | Joanne Wuensch | Neutral | Maintains | $74.00 |
| Feb 26, 2026 | Canaccord Genuity | Caitlin Cronin | Buy | Maintains | $90.00 |
| Feb 25, 2026 | Stephens & Co. | George Sellers | Overweight | Maintains | $90.00 |
| Feb 25, 2026 | Mizuho | Anthony Petrone | Outperform | Maintains | $100.00 |
| Feb 24, 2026 | Needham | Mike Matson | Buy | Maintains | $86.00 |
| Feb 24, 2026 | BTIG | Sam Eiber | Buy | Maintains | $88.00 |
| Jan 12, 2026 | Needham | Mike Matson | Buy | Reiterates | $84.00 |
| Dec 31, 2025 | BTIG | Sam Eiber | Buy | Maintains | $86.00 |
| Dec 17, 2025 | JP Morgan | Allen Gong | Overweight | Maintains | $80.00 |
| Dec 17, 2025 | Mizuho | Anthony Petrone | Outperform | Maintains | $90.00 |
| Dec 17, 2025 | Canaccord Genuity | Caitlin Cronin | Buy | Maintains | $85.00 |
| Dec 11, 2025 | Citigroup | Joanne Wuensch | Neutral | Maintains | $75.00 |
| Dec 10, 2025 | Needham | Mike Matson | Buy | Maintains | $84.00 |
| Nov 14, 2025 | BTIG | Sam Eiber | Buy | Maintains | $81.00 |
| Nov 6, 2025 | Canaccord Genuity | Caitlin Cronin | Buy | Maintains | $72.00 |
| Nov 6, 2025 | Mizuho | Anthony Petrone | Outperform | Maintains | $85.00 |
| Nov 6, 2025 | Needham | Mike Matson | Buy | Maintains | $70.00 |
| Nov 6, 2025 | JP Morgan | Allen Gong | Overweight | Maintains | $71.00 |
| Nov 5, 2025 | BTIG | Sam Eiber | Buy | Maintains | $70.00 |
| Aug 20, 2025 | Canaccord Genuity | Caitlin Cronin | Buy | Initiates | $60.00 |
Establishment Labs Holdings Inc. (ESTA) Competitors
The following stocks are similar to Establishment Labs based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ESTA
Establishment Labs
mkt cap
1.97B
Establishment Labs Holdings Inc. (ESTA) Financial Data
Establishment Labs Holdings Inc. has a market capitalization of $1.88B with a P/E ratio of -37.2x. The company generates $211.08M in trailing twelve-month revenue with a -24.2% profit margin.
Revenue growth is +45.2% quarter-over-quarter, while maintaining an operating margin of -6.1% and return on equity of -133.3%.
Valuation Metrics
Market Cap
$1.88B
Enterprise Value
$2.16B
P/E Ratio
-37.2x
PEG Ratio
0.4x
Price/Sales
9.3x
Growth & Margins
Revenue Growth (YoY)
+45.2%
Gross Margin
+70.5%
Operating Margin
-6.1%
Net Margin
-24.2%
EPS Growth
+45.2%
Financial Health
Cash/Price Ratio
+4.0%
Current Ratio
3.0x
Debt/Equity
1,123.1x
ROE
-133.3%
ROA
-6.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Establishment Labs Holdings Inc. (ESTA) Business Model
About Establishment Labs Holdings Inc.
What They Do
Manufactures medical devices for plastic surgeries.
Business Model
The company generates revenue by manufacturing and marketing a range of medical devices, primarily silicone gel-filled breast implants and body-shaping implants under the Motiva Implants brand. It sells its products directly to healthcare professionals, hospitals, and clinics, as well as through medical distributors globally, ensuring a broad reach in various international markets.
Additional Information
Established in 2004 and headquartered in Austin, Texas, the company focuses on innovative technologies for aesthetic and reconstructive procedures. It operates in multiple key regions, including Europe, Latin America, and Asia-Pacific, which positions it well within the growing global medical devices market.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
1,018
CEO
Mr. Fillipo Peter Caldini
Country
Costa Rica
IPO Year
2018
Website
www.establishmentlabs.comEstablishment Labs Holdings Inc. (ESTA) Latest News & Analysis
Latest News
Quick Summary
On April 14, 2026, 37,500 shares were sold indirectly for about $2.45 million. The insider retains 45,193 direct and 1,182,504 indirect shares post-transaction.
Why It Matters
The sale of 37,500 shares by an insider indicates potential confidence issues, impacting investor sentiment and stock price. Insider trading activity can signal shifts in company outlook.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Establishment Labs (NASDAQ: ESTA) has surpassed five million Motiva devices sold, highlighting strong global adoption and commitment to innovation in breast aesthetics and reconstruction.
Why It Matters
Surpassing five million Motiva devices indicates strong market demand and brand trust, suggesting growth potential for Establishment Labs, which could positively impact its stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Coherent is improving throughput speeds as manufacturing constraints ease. BrightSpring Health Services shows strong growth post-IPO, while Varonis Systems reported disappointing earnings and outlook.
Why It Matters
Coherent’s capacity improvements and product advancements signal growth potential. BrightSpring’s strong performance indicates robust demand, while Varonis’ poor results may raise concerns about its future.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Establishment Labs Holdings Inc. (ESTA) held its Q4 2025 earnings call, discussing financial performance and future outlook. Further details are available in the full transcript.
Why It Matters
The Q4 2025 earnings call for Establishment Labs Holdings Inc. reveals financial performance and strategic direction, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
1 month ago
Quick Summary
Establishment Labs Holdings Inc. (NASDAQ: ESTA) reported Q4 2025 revenue of $64.6M, up 45.2% year-over-year. Full-year 2025 revenue reached $211.1M, with guidance provided for 2026.
Why It Matters
Establishment Labs' strong revenue growth signals robust demand in women's health, potentially boosting investor confidence and stock performance. 2026 guidance further shapes future expectations.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Establishment Labs Holdings Inc. (ESTA) reported a quarterly loss of $0.09 per share, better than the estimated loss of $0.22, and improved from a loss of $0.98 per share a year prior.
Why It Matters
Establishment Labs' smaller-than-expected loss signals improved financial performance, potentially boosting investor confidence and stock value.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About ESTA Stock
What is Establishment Labs Holdings Inc.'s (ESTA) stock forecast for 2026?
Based on our analysis of 14 Wall Street analysts, Establishment Labs Holdings Inc. (ESTA) has a median price target of $90.00. The highest price target is $100.00 and the lowest is $65.00.
Is ESTA stock a good investment in 2026?
According to current analyst ratings, ESTA has 8 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $64.06. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ESTA stock?
Wall Street analysts predict ESTA stock could reach $90.00 in the next 12 months. This represents a 40.5% increase from the current price of $64.06. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Establishment Labs Holdings Inc.'s business model?
The company generates revenue by manufacturing and marketing a range of medical devices, primarily silicone gel-filled breast implants and body-shaping implants under the Motiva Implants brand. It sells its products directly to healthcare professionals, hospitals, and clinics, as well as through medical distributors globally, ensuring a broad reach in various international markets.
What is the highest forecasted price for ESTA Establishment Labs Holdings Inc.?
The highest price target for ESTA is $100.00 from Anthony Petrone at Mizuho, which represents a 56.1% increase from the current price of $64.06.
What is the lowest forecasted price for ESTA Establishment Labs Holdings Inc.?
The lowest price target for ESTA is $65.00 from Marie Thibault at BTIG, which represents a 1.5% increase from the current price of $64.06.
What is the overall ESTA consensus from analysts for Establishment Labs Holdings Inc.?
The overall analyst consensus for ESTA is bullish. Out of 14 Wall Street analysts, 8 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $90.00.
How accurate are ESTA stock price projections?
Stock price projections, including those for Establishment Labs Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 8:11 AM UTC